Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.48
-0.29 (-3.73%)
At close: Sep 12, 2025, 4:00 PM EDT
7.52
+0.04 (0.53%)
After-hours: Sep 12, 2025, 4:57 PM EDT
Lifecore Biomedical Revenue
In the fiscal year ending May 25, 2025, Lifecore Biomedical had annual revenue of $128.87M with 0.47% growth. Lifecore Biomedical had revenue of $36.44M in the quarter ending May 25, 2025, a decrease of -3.81%.
Revenue (ttm)
$128.87M
Revenue Growth
+0.47%
P/S Ratio
2.03
Revenue / Employee
$317,406
Employees
406
Market Cap
281.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 25, 2025 | 128.87M | 606.00K | 0.47% |
May 26, 2024 | 128.26M | 24.99M | 24.20% |
May 28, 2023 | 103.27M | -8.00M | -7.19% |
May 29, 2022 | 111.27M | 10.40M | 10.31% |
May 30, 2021 | 100.87M | -59.19M | -36.98% |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LFCR News
- 4 days ago - Lifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference - GlobeNewsWire
- 11 days ago - Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Lifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
- 6 weeks ago - Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 2 months ago - Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire